Patents Assigned to Message Pharmaceutical, Inc.
  • Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
    Patent number: 7078171
    Abstract: Described herein are methods for identifying novel nucleic acid regulatory elements and compounds that modulate the regulation of such elements. Also described herein are nucleic acid sequence identified as novel nucleic acid regulatory elements and host cells containing such nucleic acid regulatory elements in a vector.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: July 18, 2006
    Assignee: Message Pharmaceutical, Inc.
    Inventors: Anthony Giordano, Paul S. Eder, Deborah Beach McGill, Gregg Johannes